
TUMI Genomics is a biotechnology company specializing in cannabis pathogen testing and laboratory services. They provide innovative, data-driven pathogen prevention solutions and diagnostics tailored for the legal cannabis industry, helping growers maximize yields and protect crops from diseases. Their offerings include rigorous diagnostic assays, on-site testing platforms like TUMIGlow, and comprehensive scientific support through personalized programs and SOPs. The company operates globally with customers in over 15 countries and has conducted over 140,000 diagnostics. Their business model focuses on subscription and service-based revenue through custom pathogen solutions for cultivators, nurseries, tissue culture labs, and consultants. TUMI Genomics differentiates itself by combining deep scientific expertise, advanced molecular biology techniques, and AI-driven insights to raise industry standards and empower cannabis growers with reliable, actionable data.

TUMI Genomics is a biotechnology company specializing in cannabis pathogen testing and laboratory services. They provide innovative, data-driven pathogen prevention solutions and diagnostics tailored for the legal cannabis industry, helping growers maximize yields and protect crops from diseases. Their offerings include rigorous diagnostic assays, on-site testing platforms like TUMIGlow, and comprehensive scientific support through personalized programs and SOPs. The company operates globally with customers in over 15 countries and has conducted over 140,000 diagnostics. Their business model focuses on subscription and service-based revenue through custom pathogen solutions for cultivators, nurseries, tissue culture labs, and consultants. TUMI Genomics differentiates itself by combining deep scientific expertise, advanced molecular biology techniques, and AI-driven insights to raise industry standards and empower cannabis growers with reliable, actionable data.